Britain Limits Use of Puberty-Blocking Drugs to Research Only
The News Britain’s National Health Service announced on Friday that it would limit the use of puberty-suppressing drugs to children enrolled in clinical trials. The change comes as the agency’s pediatric gender services have struggled to keep up with soaring demand. A document explaining the N.H.S.’s reasoning stated that “there is not enough evidence to…